Navigation Links
Bilirubin can prevent damage from cardiovascular disease
Date:12/6/2012

COLUMBIA, Mo. -- Each year, about 610,000 Americans suffer their first heart attack, according to the Centers for Disease Control and Prevention. Heart attacks and other symptoms of cardiovascular disease can be caused when blockage occurs in the arteries. In a new study from the University of Missouri, a scientist has discovered a natural defense against arterial blockage: bilirubin.

Bilirubin is typically something parents of newborns hear about when their children are diagnosed with jaundice. Generated during the body's process to recycle worn-out red blood cells, bilirubin is metabolized by the liver and, usually, leaves the body harmlessly. (Many babies' livers are not developed enough to metabolize the bilirubin, which results in the infants being diagnosed with jaundice, or high levels of bilirubin in their systems.) Now MU scientists have found that bilirubin can be used to inhibit the clogging of arteries, and thus prevent the deadly consequences, often experienced by individuals with cardiovascular disease.

"Bilirubin is generated daily in the human body, but it's not a waste product; it has important functions, including being an antioxidant," said William Durante, professor of medical pharmacology and physiology and lead author on the study. "What we found in our study is that bilirubin can prevent or limit the damage that occurs to blood vessels in individuals who have, or are at risk for, cardiovascular diseases, such as atherosclerosis."

When arteries are damaged, smooth muscle cells in blood vessels become activated and grow at the injury sites creating lesions inside the arteries. These, lesions can block the flow of blood in arteries of the heart leading to chest pains or deadly heart attacks, Durante said. Arterial lesions can occur due to genetics or because of bad lifestyle choices such as a lack of exercise, unhealthy diet or smoking.

"We found that bilirubin could limit the size of arterial lesions by blocking the growth of vascular smooth muscle cells" Durante said. "Importantly, bilirubin inhibits cell growth without causing cell death, an undesirable side effect of drugs. Cell death creates cellular debris in the arterial network and leads to inflammation and possible rupture of the lesions resulting in even bigger clinical problems."

However, Durante said that bilirubin is a challenge to use because it is not easily dissolved in water and is rapidly metabolized by the liver when taken orally.

"One possibility is to coat stents which doctors insert into arteries to keep blood vessels open once the blockage has been cleared with the bilirubin," Durante said. "When the stents are inserted into the arteries, bilirubin will keep smooth muscle cells from growing and blocking the stent. Surgeons also could coat bilirubin onto blood vessels that are used in bypass surgery."

Durante said that further studies are needed before this technique can be tested in humans. Durante's study was published in Frontiers in Pharmacology. The early-stage results of this research are promising. If additional studies, including animal studies, are successful within the next few years, MU officials would request authority from the federal government to begin human drug development (this is commonly referred to as the "investigative new drug" status). After this status has been granted, researchers may conduct human clinical trials with the hope of developing new treatments.


'/>"/>
Contact: Christian Basi
BasiC@missouri.edu
573-882-4430
University of Missouri-Columbia
Source:Eurekalert  

Related biology news :

1. Preventing home invasions means fighting side-by-side for coral-dwelling crabs and shrimp
2. Commonly used diabetes drug may help to prevent primary liver cancer
3. New discovery may lead to effective prevention and treatment of graft-versus-host dsease
4. How many calories does it take to reach childhood obesity prevention goals?
5. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
6. New product to replace fishmeal could help prevent global food shortage
7. Clinical trials for Alzheimers disease preventative drug to begin early 2013
8. Preventice Expands Options for Wireless Patient Monitoring with Qualcomm Life
9. New paints prevent fouling of ships hulls
10. IOC recognizes University of Calgary Sports Injury Research Prevention Centre
11. Preventing the immune system from going haywire during sepsis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bilirubin can prevent damage from cardiovascular disease
(Date:3/20/2017)... March 20, 2017 PMD Healthcare announces the ... and Wellness Management System (WMS), a remote, real-time lung ... 2010, PMD Healthcare is a Medical Device, Digital Health, ... dedicated to creating innovative solutions that empower people to ... intent focus, PMD developed the first ever personal spirometer, ...
(Date:3/9/2017)... Australia , March 9, 2017 4Dx ... prestigious World Lung Imaging Workshop at the University of ... was invited to deliver the latest data to world ... recognised event brings together leaders at the forefront of ... in lung imaging. "The quality of ...
(Date:3/7/2017)... 2017   HireVue , the leading provider of ... the best talent, faster, today announced the additions of ... and Diana Kucer as Chief Marketing Officer ... team poised to drive continued growth in the company,s ... of record bookings in 2017. "Companies worldwide ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... 2017 The Global Microfluidic Chips Market by ... specialized and comprehensive study on the existing state of the global ... Europe and Asia-Pacific , ... and Africa . ... Browse 172 Tables and Figures, 13 Major ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today that Scandinavian ... training plan management for consistent implementation of standards and regulatory requirements across SHL ... to help improve and streamline their training and employee development programs, which are ...
(Date:3/28/2017)... ... 2017 , ... Franz Inc ., the leading supplier of Semantic Graph ... a ‘Champion’ by Bloor Research in its recent Graph Database Market Update ... thanks to Gruff, it was rated as the easiest product to use.” – Bloor ...
(Date:3/28/2017)... ... March 28, 2017 , ... Ecovia ... Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). Under the ... to develop a suite of BioGel™ biopolymer materials for hygiene applications, particularly for ...
Breaking Biology Technology: